Learn more about whether ACADIA Pharmaceuticals Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that relies on harnessing patients' cancer-fighting capabilities. Iovance's shares ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Biotech has a big footprint in Massachusetts, and according to a 2023 report, women make up less than 6% of leadership roles ...

Natural insecticide developer has won $3 million of US military grants to tackle the problems of mosquito-borne diseases, ...

During its Q4 2024 earnings call, Alexandria Real Estate Equities laid out its strategy for a challenging market and praised ...

Learn more about whether Legend Biotech Corporation or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

Just after market close on Monday, 89bio divulged that it intends to raise as much as $287.5 million from a secondary stock issue. It will do so in an underwritten public offering of $250 million ...

There is a need for nuanced immigration policies that emphasise the complementary relationship between foreign talent and ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...